Showing 4881-4890 of 5957 results for "".
- Merck Shuts Down Covid Vaccine Program After Lackluster Datahttps://modernod.com/news/merck-shuts-down-covid-vaccine-program-after-lackluster-data/2478791/Merck is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines, according to a Bloomberg
- Genentech’s Faricimab Meets Primary Endpoint in Two Global Phase 3 Studies in Wet AMDhttps://modernod.com/news/genentechs-faricimab-meets-primary-endpoint-in-two-global-phase-3-studies-in-wet-amd/2478792/Genentech announced positive topline results from two identically designed global phase 3 studies, TENAYA and LUCERNE, evaluating its investigational bispecific antibody, faricimab, in people living with wet age-related macular degeneration (AMD). Both studies met their primary endpoint and showe
- Ace Vision Group Closes Series A Stock Round to Advance Ophthalmic Technologieshttps://modernod.com/news/ace-vision-group-closes-series-a-stock-round-to-advance-ophthalmic-technologies/2478790/Ace Vision Group announced that it closed a Series A preferred stock round totaling $13.3 million ($3.3 million oversubscribed) to continue development and commercialization of its VisioLite Ophthalmic Laser, a touchless therapeutic device being developed for the treatment of age-related vision d
- Lilly’s Bamlanivimab Cuts Risk of COVID-19 By Up to 80% at Nursing Homeshttps://modernod.com/news/lillys-bamlanivimab-cuts-risk-of-covid-19-by-up-to-80-at-nursing-homes/2478788/Eli Lilly announced Thursday that in a phase 3 study, bamlanivimab was shown to significantly reduce the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities. The findings from the BLAZE-2 COVID-19 prevention trial suggest the risk was decreased by up to
- VSY Biotechnology Introduces Protectalon DUO Kithttps://modernod.com/news/vsy-biotechnology-introduces-protectalon-duo-kit/2478778/VSY Biotechnology has introduced the Protectalon DUO Kit, which is designed to help eye care professionals meet their OVD needs at different stages of cataract surgery with a single kit. The Protectalon DUO Kit features a Dual Pack containing one unit cohesive (14 mg/mL, 1.1 mL) and one un
- EyeCare Partners Acquires of Several Oklahoma-Based Independent Ophthalmology Practiceshttps://modernod.com/news/eyecare-partners-acquires-of-several-oklahoma-based-independent-ophthalmology-practices/2478776/EyeCare Partners has acquired multiple independent ophthalmology practices in Oklahoma City. The deal includes four ophthalmologists from three individual practices with six office locations and two ambulatory surgery centers. Epic Vision, Cataract Institute of Oklahoma, Precision Vision, and Eye
- Rayner Enters Canadian Ophthalmology Markethttps://modernod.com/news/rayner-enters-canadian-ophthalmology-market/2478773/Following the recent approval of incorporation, Rayner announced that is will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. The entry into the Canadian market will be led by Wade Allen, Director: Americas, Rayner Surgical Corp. The RayOne Aspheri
- Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 (Perfluorohexyloctane)https://modernod.com/news/bausch-lomb-completes-enrollment-of-first-phase-3-study-for-nov03-perfluorohexyloctane/2478770/Bausch + Lomb and Novaliq announced the first of two phase 3 studies evaluating NOV03 as a first-in-class investigational drug with a novel mechanism of action to treat the signs and symptoms of dry eye disease (DED) associated with Meibomian gland dysfunction (MGD) has been completely enrolled w
- Study: Implandata’s Eyemate System Protects Glaucoma Patients–Even During Lockdownhttps://modernod.com/news/study-implandatas-eyemate-system-protects-glaucoma-patients-even-during-lockdown/2478767/Patients with glaucoma are at high risk of losing their eyesight if their disease progresses undetected and essential therapy adjustments are delayed. On the other hand, these typically elderly, vulnerable individuals are often hampered in seeing their doctor for office visits, particularly durin
- Printable Chart Suitable for Stay-at-Home Visual Evaluationhttps://modernod.com/news/printable-chart-suitable-for-stay-at-home-visual-evaluation/2478763/A chart that can be downloaded or printed and mailed to patients appears effective in helping determine visual acuity via telephone assessments, according to researchers in the UK, Reuters reported. “We are excited to be deve